Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy Plus CCRT vs CCRT Alone in Low-risk Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05979961Phase 3Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2023
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Sep 2023; status: active, not recruiting.
02
Drugs
gemcitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT05979961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05979961.